nerolidol has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adrian, TE; Al-Ramadi, BK; Almarzooqi, S; Ojha, SK; Raj, V; Subramanian, VS; Subramanya, SB; Venkataraman, B | 1 |
| Adeghate, E; Amir, N; Bastaki, SMA; Ojha, S | 1 |
2 other study(ies) available for nerolidol and Colitis
| Article | Year |
|---|---|
Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies.
Topics: Caco-2 Cells; Colitis; Cytokines; Dextran Sulfate; Humans; Inflammation; Intestinal Mucosa; Lipopolysaccharides; Mitogen-Activated Protein Kinases; NF-kappa B; Sesquiterpenes; Signal Transduction; Tight Junction Proteins; Tight Junctions | 2023 |
Nerolidol, a sesquiterpene, attenuates oxidative stress and inflammation in acetic acid-induced colitis in rats.
Topics: Acetic Acid; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antioxidants; Colitis; Cytokines; Glutathione; Inflammation; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Wistar; Sesquiterpenes | 2021 |